Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study
Abstract Background Methotrexate (MTX) is an anchor drug used for the treatment of rheumatoid arthritis (RA); hence, understanding the reasons for MTX discontinuation in RA can help improve its treatment. Therefore, this study aimed to investigate the reasons for MTX discontinuation and to identify...
Main Authors: | Hiroko Nagafuchi, Yutaka Goto, Tomofumi Kiyokawa, Kimito Kawahata |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-12-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-022-00162-w |
Similar Items
-
Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
by: Chen HH, et al.
Published: (2016-02-01) -
Methotrexate intolerance in Rheumatoid Arthritis
by: Harjit Singh Nalwa, et al.
Published: (2023-03-01) -
Patterns of Cytopenias Associated with Methotrexate Treated Rheumatoid Arthritis Patients
by: Mohsin Shakoor Malik, et al.
Published: (2023-04-01) -
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01) -
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)